Janet Woodcock: Difference between revisions

Latest revision as of 11:31, 15 February 2025

American physician and public health administrator

Janet Woodcock is an American physician and public health administrator who has played a significant role in the FDA. She is known for her work in drug regulation and public health policy.

Early Life and Education[edit]

Janet Woodcock was born in Washington, Pennsylvania. She attended Bucknell University, where she earned a Bachelor of Science degree in chemistry. She then went on to receive her medical degree from the Northwestern University Feinberg School of Medicine.

Career[edit]

Early Career[edit]

After completing her medical training, Woodcock worked in various medical and research positions. She was involved in clinical research and patient care, which laid the foundation for her future work in drug regulation.

FDA Career[edit]

Woodcock joined the FDA in 1986. She has held several key positions within the agency, including Director of the Center for Drug Evaluation and Research (CDER). In this role, she was responsible for overseeing the evaluation and approval of new drugs, ensuring their safety and efficacy for public use.

Acting Commissioner[edit]

In 2021, Woodcock served as the Acting Commissioner of the FDA. During her tenure, she focused on addressing the challenges posed by the COVID-19 pandemic, including the approval and distribution of COVID-19 vaccines.

Contributions to Drug Regulation[edit]

Woodcock has been a strong advocate for modernizing the drug approval process. She has worked to implement new technologies and methodologies to improve the efficiency and effectiveness of drug evaluations. Her efforts have been instrumental in advancing the FDA's mission to protect public health.

Awards and Recognition[edit]

Throughout her career, Woodcock has received numerous awards for her contributions to public health and drug regulation. Her leadership and dedication have been recognized by various professional organizations and government bodies.

Related pages[edit]

@@ Line 1: / Line 1: @@
-{{png-image}}
+{{short description|American physician and public health administrator}}
+{{Use American English|date=October 2023}}
+{{Use mdy dates|date=October 2023}}
-Janet Woodcock is a prominent figure in the field of [[pharmaceuticals]] and [[public health]], best known for her long-standing service within the [[United States Food and Drug Administration]] ([[FDA]]). Over her career, Woodcock has played a critical role in the development, evaluation, and approval of [[medications]], making significant contributions to [[drug safety]] and [[regulatory science]].
+[[File:Janet_Woodcock_(2021).png|thumb|right|Janet Woodcock in 2021]]
-Born on April 27, 1948, Woodcock earned her bachelor's degree in [[chemistry]] from Bucknell University in 1970 and her M.D. from the Feinberg School of Medicine at Northwestern University in 1977. Following her medical training, she completed further studies in [[rheumatology]] and [[internal medicine]] at the University of Pennsylvania.
+'''Janet Woodcock''' is an American physician and public health administrator who has played a significant role in the [[United States Food and Drug Administration|FDA]]. She is known for her work in drug regulation and public health policy.
-Woodcock joined the FDA in 1986, initially working in the [[Center for Biologics Evaluation and Research]] (CBER). Her expertise and leadership skills soon led her to take on more significant roles within the agency. In 1994, she was appointed Director of the [[Center for Drug Evaluation and Research]] (CDER), where she served for over two decades in various capacities. Under her direction, CDER focused on modernizing the drug approval process, enhancing the safety of marketed drugs, and facilitating the development of novel therapeutics.
+==Early Life and Education==
+Janet Woodcock was born in [[Washington, Pennsylvania]]. She attended [[Bucknell University]], where she earned a Bachelor of Science degree in chemistry. She then went on to receive her medical degree from the [[Northwestern University Feinberg School of Medicine]].
-Throughout her tenure at the FDA, Woodcock has been involved in the implementation of several key legislative acts aimed at improving drug development and approval processes. These include the [[Prescription Drug User Fee Act]] (PDUFA), which allows the FDA to collect fees from drug manufacturers to fund the new drug approval process, and the [[21st Century Cures Act]], which aims to accelerate medical product development and bring new innovations and advances to patients who need them faster and more efficiently.
+==Career==
+===Early Career===
+After completing her medical training, Woodcock worked in various medical and research positions. She was involved in clinical research and patient care, which laid the foundation for her future work in drug regulation.
-Woodcock's work has not been without controversy. Some of her decisions, particularly those involving drug approvals and the regulation of [[opioids]], have faced criticism from public health advocates and some members of Congress. Despite this, her contributions to the field of drug regulation and her commitment to public health have been widely recognized. She has received numerous awards and honors for her work, including the Presidential Rank Award, which is the highest award given to career federal employees.
+===FDA Career===
+Woodcock joined the [[United States Food and Drug Administration|FDA]] in 1986. She has held several key positions within the agency, including Director of the Center for Drug Evaluation and Research (CDER). In this role, she was responsible for overseeing the evaluation and approval of new drugs, ensuring their safety and efficacy for public use.
-In addition to her regulatory work, Woodcock has been an advocate for advancing regulatory science, the science of developing new tools, standards, and approaches to assess the safety, efficacy, quality, and performance of FDA-regulated products. She has emphasized the importance of building a robust regulatory framework that can adapt to scientific innovations and ensure that regulatory decisions are based on the best available science.
+===Acting Commissioner===
+In 2021, Woodcock served as the Acting Commissioner of the FDA. During her tenure, she focused on addressing the challenges posed by the [[COVID-19 pandemic]], including the approval and distribution of [[COVID-19 vaccines]].
-Woodcock's career at the FDA has been marked by her dedication to public health and her efforts to ensure that safe and effective drugs are available to the American public. Her leadership and vision have had a lasting impact on the field of drug regulation and on the health and well-being of millions of people.
+==Contributions to Drug Regulation==
+Woodcock has been a strong advocate for modernizing the drug approval process. She has worked to implement new technologies and methodologies to improve the efficiency and effectiveness of drug evaluations. Her efforts have been instrumental in advancing the FDA's mission to protect public health.
-[[Category:Pharmaceuticals]]
+==Awards and Recognition==
-[[Category:Public Health]]
+Throughout her career, Woodcock has received numerous awards for her contributions to public health and drug regulation. Her leadership and dedication have been recognized by various professional organizations and government bodies.
-[[Category:United States Food and Drug Administration]]
-{{medicine-stub}}
+==Related pages==
+* [[United States Food and Drug Administration]]
+* [[COVID-19 pandemic]]
+* [[Drug regulation]]
+[[Category:American physicians]]
+[[Category:Public health officials]]
+[[Category:Living people]]